Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inovamed AG is a Swiss specialty pharmaceutical company focused on the marketing and distribution of innovative medicines and medical devices. The company specializes in therapeutic areas such as nephrology, oncology, intensive care, and rare diseases, often acting as a strategic partner for international pharmaceutical firms seeking to enter the Swiss market. Inovamed provides comprehensive services including regulatory affairs, market access, and commercialization. Their portfolio includes established treatments for iron deficiency and hyperphosphatemia, as well as specialized supportive care products for cancer patients. By leveraging local expertise, Inovamed bridges the gap between global drug developers and the Swiss healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inovamed.